PROTEIN, METHOD OF PROTEIN PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION Russian patent published in 1998 - IPC

Abstract RU 2124024 C1

FIELD: chemistry of proteins, biochemistry. SUBSTANCE: invention relates to a protein - antagonist of hepatocyte growth factor (HGF) and can be used in biotechnology and medicine. Protein consists of two α-- and β--chains connected by disulfide bond and can bind with HGF but has no domain of cytoplasmic tyrosine kinase. α--Chain is α--chain of receptors of HGF encoded by protooncogen MET (molecular mass is 50 kDa). α--Chain is a form of β--chain of HGF receptors (molecular mass is 75 or 85 kDa) and it is truncated from C-end. Protein is produced by culturing cells expressing MET gene. For isolation from cultural fluid protein is bound with antibodies showing specificity to extracellular domain of β--chain of receptor. Invention ensures to obtain the truncated forms of HGF receptor and use their for pharmaceutical preparations preparing. EFFECT: improved method of preparing and isolation of protein. 5 cl, 13 dwg, 2 ex

Similar patents RU2124024C1

Title Year Author Number
PEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING 1994
  • Paolo Komolio
  • Karola Pontsetto
RU2146262C1
G-PROTEIN COUPLED RECEPTORS DROSOPHILA, NUCLEIC ACIDS AND RELATED METHODS 2003
  • Louehri Dehvid Eh.
  • Smit Valdin G.
  • Kubjak Tereza M.
  • Larsen Marta Dzh.
RU2326385C2
CONJUGATE TO STIMULATE IMMUNE RESPONSE AGAINST A TARGET CELL, METHOD TO TREAT MALIGNANT TUMORS IN MAMMALIANS 1995
  • Abrakhmsen Lars
  • B'Erk Per
  • Dokhlsten Mikaehl'
  • Kalland Ter'E
RU2183215C2
DNA MOLECULE ENCODING POLYPEPTIDE ABLE TO BIND WITH INTRACELLULAR DOMAIN OF FAS (FAS-IC) LIGAND RECEPTOR, POLYPEPTIDE, METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATION OF EFFECT OF FAS-R LIGAND ON CELLS (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEIN 1995
  • Uollakh Dehvid
  • Boldin Mark
  • Varfolomeev Evgenij
  • Mett Igor'
RU2241747C2
METHOD FOR PREPARING DOXORUBICIN AND AGENTS FOR ITS REALIZATION 1996
  • Solari Inventi Avgusto
  • Breme Umberto
  • Kolombo Anna Luiza
  • Khatchinson Charlz Richard
  • Otten Sheri
  • Skotti Klaudio
RU2205222C2
BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS 1991
  • Franchesko Andzheluchchi
  • Laura Bersani
  • Mikele Karuzo
  • Marina Ripamonti
  • Daniehla Rudzheri
  • Antonino Suarato
RU2116087C1
POLYPEPTIDE SHOWING CARMINOMYCIN-4-O-METHYLTRANSFERASE ACTIVITY AND A METHOD OF ITS PREPARING 1992
  • Charl'Z Richard Khatchinson
  • Krishna Marti Madduri
  • Francheska Torti
  • Anna Luiza Kolombo
RU2115731C1
METHODS AND COMPOSITIONS FOR ACTIVATION MODULATION OF HEPATOCYTE GROWTH FACTOR 2005
  • Kirkhkhofer Dehniel K.
  • Moran Pol M.
  • Pik Mark D.
RU2405041C2
CONJUGATE ELICITING ABILITY TO ACTIVATE IMMUNE SYSTEM AND PHARMACEUTICAL COMPOSITION COMPRISING INDICATED CONJUGATE 1997
  • Antonsson Per
  • Khansson Jokhan
  • B'Erk Per
  • Dol'Sten Mikaehl'
  • Kalland Ter'E
  • Abramsen Lars
  • Forsberg Jeran
RU2198895C2
ANTIBODY AGAINST INTERFERON-ALPHA/BETA-CONNECTING PROTEIN II (IFNAB-BPII) 1995
  • Kokhen Batija
  • Novik Daniela
  • Rubinshtejn Menakhem
RU2362781C2

RU 2 124 024 C1

Authors

Paolo Komol'O

Titsiana Krepal'Di

Marija Prat

Dates

1998-12-27Published

1992-04-30Filed